Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
61.98
+3.37 (5.75%)
At close: Feb 18, 2026

Chugai Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
100,21386,52273,25462,35142,01353,339
Market Cap Growth
44.68%18.11%17.49%48.41%-21.23%-39.15%
Enterprise Value
93,86680,89367,87757,96137,87849,894
Last Close Price
61.9854.9141.0735.8724.8231.33
PE Ratio
36.2031.2629.7427.0014.8020.27
PS Ratio
12.4910.789.847.914.406.14
PB Ratio
7.766.706.065.413.895.17
P/TBV Ratio
7.976.886.115.473.965.27
P/FCF Ratio
50.6843.7629.0026.0130.5328.74
P/OCF Ratio
40.6835.1225.7321.4422.7021.96
EV/Sales Ratio
11.5210.089.127.353.975.75
EV/EBITDA Ratio
23.2720.5718.6017.358.8512.69
EV/EBIT Ratio
24.5521.4919.6918.609.3713.62
EV/FCF Ratio
47.4740.9126.8724.1727.5226.89
Debt / Equity Ratio
--0.010.010.010.01
Debt / EBITDA Ratio
--0.020.030.020.04
Debt / FCF Ratio
--0.030.040.080.08
Net Debt / Equity Ratio
-0.48-0.48-0.52-0.45-0.34-0.38
Net Debt / EBITDA Ratio
-1.59-1.59-1.72-1.54-0.87-1.01
Net Debt / FCF Ratio
-3.16-3.16-2.48-2.15-2.69-2.13
Asset Turnover
0.540.540.560.590.740.72
Inventory Turnover
1.411.411.321.461.901.72
Quick Ratio
3.463.464.593.682.402.53
Current Ratio
4.244.245.534.743.153.25
Return on Equity (ROE)
22.10%22.10%21.96%21.34%28.67%27.95%
Return on Assets (ROA)
15.77%15.77%16.36%14.44%19.56%19.01%
Return on Invested Capital (ROIC)
41.72%43.67%42.57%35.09%45.09%45.33%
Return on Capital Employed (ROCE)
28.70%28.70%28.30%26.70%36.90%34.80%
Earnings Yield
2.76%3.20%3.36%3.70%6.76%4.93%
FCF Yield
1.97%2.28%3.45%3.84%3.28%3.48%
Dividend Yield
2.91%1.42%1.52%1.58%2.38%2.11%
Payout Ratio
68.99%68.99%34.40%40.43%36.91%32.56%
Buyback Yield / Dilution
-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Total Shareholder Return
2.91%1.41%1.51%1.57%2.38%2.10%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.